Nowadays, antibiotic medication research is a crucial procedure to battle harmful microorganisms and developing infectious diseases to threaten people’s health and well-being around the world. Novel antibiotics are now necessary than ever due to emergence of new diseases and the drug resistance than older infectious diseases generated. However, Actinomycetes are the most varied classes of filamentous bacteria, widely distributed and known for their adaptable metabolism. These bacteria’s bioactive potential helps them survive even under adverse and undesirable environmental circumstances. Actinomycetes have a high degree of genetic and functional variety, and also variation in the production of secondary metabolites, which have advantages in industrial, medicinal and environmental restoration. Bioactive compounds produced from Actinomycetes are a rich source of antifungal, antibacterial, anthelmintics and anticancer agents. Actinomycetes are potential sources of novel compounds to battle multidrug resistance in pathogenic bacteria; in addition actinomycetes-derived medicines are useful in therapeutic appliances. Other role of actinomycetes such as transformation of organic soil components into hums as degrading agents, secretion of variety of enzymes that are capable of totally destroying all the constituents and are useful in the bioremediation of pesticides, toxic metals, nuclear waste, detergents, food preservatives and biofouling applications. The use of actinomycetes will likely increase in the future when integrated with gene therapy, microbial molecular development and other improvement techniques also reviewed in this paper. Applications in biotechnology and healthcare can benefit from the incorporation of modern habitats, screening and enhancement technologies. With an emphasis on actinomycetes isolates, this review paper summarizes the state of art of actinomycetes utilization in biotechnological research and offers recommendations for future study.

Actinomycetes, Enzymes, Antibiotics, Metabolites, anticancer and bioremediation